» Articles » PMID: 14680669

On Crude and Age-adjusted Relative Survival Rates

Overview
Publisher Elsevier
Specialty Public Health
Date 2003 Dec 19
PMID 14680669
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Relative survival rates, such as 5- or 10-year relative survival rates, which quantify "net survival" of cancer patients, are the most commonly reported measures of cancer outcome by cancer registries. Because relative survival rates vary with age for many forms of cancer, and because the age distribution of cancer patients varies between different populations or within one population over time, age adjustment of relative survival rates is often employed in international comparisons or in time series analyses of cancer patient survival. In this article, we show that derivation of crude and of age-adjusted relative survival rates in the traditional way is conceptually inconsistent, and that this inconsistency has important practical implications. We show ways to overcome this inconsistency in the derivation and interpretation of crude and age-adjusted relative survival rates.

Citing Articles

Children With Acute Lymphoblastic Leukemia in Romania: Results From a Decade-Long Single-Center Study.

Neaga A, Jimbu L, Mesaros O, Blag C, Zdrenghea M Cureus. 2024; 16(9):e70166.

PMID: 39463583 PMC: 11505573. DOI: 10.7759/cureus.70166.


Geographic variations in lipid-lowering therapy utilization, LDL-C levels, and proportion retrospectively meeting the ACC/AHA very high-risk criteria in a real-world population of patients with major atherosclerotic cardiovascular disease events in....

Baum S, Rane P, Nunna S, Habib M, Philip K, Sun K Am J Prev Cardiol. 2021; 6:100177.

PMID: 34327500 PMC: 8315617. DOI: 10.1016/j.ajpc.2021.100177.


The world cancer patient population (WCPP): An updated standard for international comparisons of population-based survival.

Miranda-Filho A, Bray F, Charvat H, Rajaraman S, Soerjomataram I Cancer Epidemiol. 2020; 69:101802.

PMID: 32942139 PMC: 7768180. DOI: 10.1016/j.canep.2020.101802.


Marginal measures and causal effects using the relative survival framework.

Syriopoulou E, Rutherford M, Lambert P Int J Epidemiol. 2020; 49(2):619-628.

PMID: 31953948 PMC: 7266533. DOI: 10.1093/ije/dyz268.


Stage IV melanoma of unknown primary: A population-based study in the United States from 1973 to 2014.

Scott J, Conic R, Thompson C, Gerstenblith M, Bordeaux J J Am Acad Dermatol. 2018; 79(2):258-265.e4.

PMID: 29580859 PMC: 6050094. DOI: 10.1016/j.jaad.2018.03.021.